For the first time, weekly cisplatin plus radiotherapy (CDDP+RT) has been shown to be not only less toxic than dosing once every three weeks but also achieves better outcomes in patients with ...
Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. Fifty patients with advanced gastric cancer treated with a weekly ...
Intrapatient dose escalation to 800 mg/m2 pemetrexed is safe and feasible in patients with advanced non-small cell lung cancer (NSCLC) who have had prior chemotherapy No significant financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results